During the last session, Prime Medicine Inc (NASDAQ:PRME)’s traded shares were 0.46 million, with the beta value of the company hitting 2.15. The 52-week high
In the last trading session, 1.74 million shares of the Prime Medicine Inc (NASDAQ:PRME) were traded, and its beta was 2.20. Most recently the company’s
Prime Medicine Inc (NASDAQ:PRME)’s traded shares stood at 1.82 million during the last session, with the company’s beta value hitting 2.09. At the close of
In the last trading session, 2.56 million Prime Medicine Inc (NASDAQ:PRME) shares changed hands as the company’s beta touched 1.94. With the company’s per share
In the last trading session, 2.73 million Prime Medicine Inc (NASDAQ:PRME) shares changed hands as the company’s beta touched 1.92. With the company’s per share
In recent trading session, Prime Medicine Inc (NASDAQ:PRME) saw 0.35 million shares changing hands at last check today with its beta currently measuring 1.89. Company’s
Prime Medicine Inc (NASDAQ:PRME) has a beta value of 1.87 and has seen 2.89 million shares traded in the last trading session. The PRME stock
Prime Medicine Inc (NASDAQ:PRME) has a beta value of 1.87 and has seen 0.57 million shares traded in the recent trading session. The company, currently
During the last session, Prime Medicine Inc (NASDAQ:PRME)’s traded shares were 1.43 million, with the beta value of the company hitting 1.94. At the end
During the last session, Prime Medicine Inc (NASDAQ:PRME)’s traded shares were 1.08 million, with the beta value of the company hitting 1.95. The 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne